Navigation Links
New Jersey Targets Life-Sciences Investors at World's Largest Biotechnology Event
Date:6/21/2011

PRINCETON, N.J., June 21, 2011 /PRNewswire/ -- On June 28, Lieutenant Governor Kim Guadagno, Tracye McDaniel, president and CEO of Choose New Jersey (the state's independently funded and operated nonprofit economic development organization) and Dr. Jay Tischfield, CEO, Rutgers University Cell & DNA Repository (RUCDR) are traveling to Washington, DC, to meet with investors and tout New Jersey's life-sciences industries at the world's largest biotechnology event, the 2011 BIO International Convention.

At the BIO Convention, the delegation will showcase financial incentive programs that assist both major corporations and emerging healthcare companies which have a proven track record in investment attraction and job creation. Bayer HealthCare's announcement in April to consolidate its East Coast business in New Jersey and the opening of Watson Pharmaceuticals' new global headquarters in Parsippany this month can be credited, in part, to the state's business-friendly policies. These projects will directly impact 2,000 jobs in the state.

"New Jersey offers unparalleled opportunities for pharmaceutical, biotechnology and medical device businesses. Raising awareness of these assets – like access to capital and to one of the best-educated and highly-skilled workforces in the country – is instrumental in our efforts to attract and retain companies in the state," said Tracye McDaniel, president and CEO of Choose New Jersey. "The considerable concentration of life-science businesses in New Jersey and recent investments from major corporations are a testament to what the region has to offer."

In addition, world-renowned geneticist Dr. Jay Tischfield will be on hand to highlight groundbreaking mental health research at RUCDR. The globally-recognized repository serves almost 300 clients including nearly every major medical and research school in the country, leading organizations such as the National Institute for Mental Health and Autism Speaks, and major corporations. As a professor of genetics at Rutgers University, Dr. Tischfield will also provide insight on New Jersey's highly-educated workforce, which consistently ranks among the nation's top for degreed professionals within science and engineering.  

Along with attending the conference, Choose New Jersey will host a C-level executive event to provide networking opportunities to further promote the state's biotechnology and pharmaceutical industries.

Choose New Jersey:

Choose New Jersey is an independently-funded and operated nonprofit corporation created to promote New Jersey as a place to invest and do business. For more information visit: www.chooseNJ.com.


'/>"/>
SOURCE Choose New Jersey
Copyright©2010 PR Newswire.
All rights reserved

Related biology technology :

1. Stem Cell Transplantation Program at Hackensack University Medical Center: First in Nation to Receive Joint Commission Certification for Quality and First in New Jersey to be Named a Blue Distinction(R) Center for Specialty Care.
2. Environmental Tectonics Corporation Announces the Placement of Two Monoplace Hyperbaric Chambers at Saint Barnabas Medical Center in New Jersey
3. ERYtech Pharma Signs an Agreement With the Penn Jersey Region of American Red Cross
4. NeoStem Expands Stem Cell Collection Center Network Into New Jersey Led by Leading Plastic Surgeon and Anti-Aging Authority
5. ChemOutsourcing Unveils 2009 Attendee List for September Show in New Jersey
6. New Jersey Surgery Centers Pick Health Informatics Consulting to Implement Patient Electronic Health Record Systems
7. New Jerseys Best and Brightest Minds Discuss Challenges Facing Medical Innovation, Call for Policies to Preserve U.S. Leadership in Research and Development
8. Lunch and Learn Workshop for New Jersey-based FDA-Regulated Companies
9. Archimedes Pharma US Announces New US Headquarters In Bedminster, New Jersey
10. SOCMA President to Lead ChemOutsourcing Keynote Panel on API Supply Base on Wednesday, September 15 at New Jersey Show
11. Dendreon Submits Post-Approval Supplement to the PROVENGE Biologics License Application for New Jersey Manufacturing Facility
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:10/12/2017)... ... , ... AMRI, a global contract research, development and manufacturing ... and quality of life, will now be offering its impurity solutions as a ... requirements for all new drug products, including the finalization of ICH M7 earlier ...
(Date:10/11/2017)... ... October 11, 2017 , ... ... Andi Purple announced Dr. Suneel I. Sheikh, the co-founder, CEO and chief research ... Inc. has been selected for membership in ARCS Alumni Hall of Fame ...
(Date:10/11/2017)... ... 11, 2017 , ... Personal eye wash is a basic first aid supply for any work ... which eye do you rinse first if a dangerous substance enters both eyes? It’s one ... with its unique dual eye piece. , “Whether its dirt and debris, or an ...
(Date:10/11/2017)... ... October 11, 2017 , ... Proscia Inc ., ... a Webinar titled, “Pathology is going digital. Is your lab ready?” with Dr. ... best practices and how Proscia improves lab economics and realizes an increase in ...
Breaking Biology Technology:
(Date:4/11/2017)... Florida , April 11, 2017 ... a security technology company, announces the appointment of independent Directors ... Bendheim to its Board of Directors, furthering the company,s ... ... of NXT-ID, we look forward to their guidance and benefiting ...
(Date:4/5/2017)... YORK , April 5, 2017 Today ... is announcing that the server component of the HYPR ... known for providing the end-to-end security architecture that empowers ... HYPR has already secured over 15 million ... makers including manufacturers of connected home product suites and ...
(Date:4/3/2017)...  Data captured by IsoCode, IsoPlexis Corporation,s ... statistically significant association between the potency of ... objective response of cancer patients post-treatment. The ... cancer patients will respond to CAR-T cell ... to improve both pre-infusion potency testing and cell ...
Breaking Biology News(10 mins):